MARKET

ELUT

ELUT

Elutia Inc.
NASDAQ
0.9990
+0.0509
+5.37%
After Hours: 0.9990 0 0.00% 16:10 06/26 EDT
OPEN
0.9362
PREV CLOSE
0.9481
HIGH
0.9990
LOW
0.9361
VOLUME
91.82K
TURNOVER
--
52 WEEK HIGH
2.640
52 WEEK LOW
0.5000
MARKET CAP
44.16M
P/E (TTM)
0.8610
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ELUT last week (0615-0619)?
Weekly Report · 6d ago
Elutia Shareholders Approve Amended Incentive Plan and Governance
TipRanks · 06/16 22:33
Elutia shareholders back annual say-on-pay vote frequency at meeting
PUBT · 06/16 21:00
Weekly Report: what happened at ELUT last week (0608-0612)?
Weekly Report · 06/15 09:23
Elutia to present at Planet MicroCap Showcase, host investor one-on-ones
PUBT · 06/11 20:05
Elutia to Present at Planet MicroCap Showcase 2026 on June 17th
Barchart · 06/11 15:05
Weekly Report: what happened at ELUT last week (0601-0605)?
Weekly Report · 06/08 09:21
Weekly Report: what happened at ELUT last week (0525-0529)?
Weekly Report · 06/01 09:23
More
About ELUT
Elutia Inc. is a commercial-stage company, which has developed a portfolio of products using both human and porcine tissue. Its portfolio of products spans the Women’s Health and Cardiovascular markets. In Women’s Health, it offers SimpliDerm, a novel biological matrix that leverages the inherent science of natural healing processes. SimpliDerm's design uses human-based hydrated acellular dermal matrix (ADM), which mitigates inflammation and enhances tissue incorporation. In Cardiovascular, it sells its specialized porcine small intestine submucosa for use as an intracardiac and vascular patch, as well as for pericardial reconstruction. In addition, its TYKE product is designed for use in the neonatal patient population. It is focused on advancing NXT-41x, a biomatrix that directly addresses the root causes of reconstruction infections following mastectomy. NXT-41x combines biologics and extended antibiotic release to provide protection while supporting tissue regeneration.

Webull offers Elutia Inc stock information, including NASDAQ: ELUT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ELUT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ELUT stock methods without spending real money on the virtual paper trading platform.